Atai Beckley, Inc. (ATAI)
7.355
0.00 (0.00%)
USD |
NASDAQ |
Aug 28, 14:21
Atai Beckley Cash from Operations (Quarterly) : -35.09M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -35.09M |
| March 31, 2026 | -21.09M |
| December 31, 2025 | -48.15M |
| September 30, 2025 | -24.60M |
| June 30, 2025 | -15.30M |
| March 31, 2025 | -17.84M |
| September 30, 2024 | -20.10M |
| June 30, 2024 | -16.07M |
| March 31, 2024 | -22.57M |
| December 31, 2023 | -21.10M |
| September 30, 2023 | -18.54M |
| June 30, 2023 | -22.93M |
| March 31, 2023 | -21.11M |
| Date | Value |
|---|---|
| December 31, 2022 | -31.71M |
| September 30, 2022 | -24.95M |
| June 30, 2022 | -20.75M |
| March 31, 2022 | -23.99M |
| December 31, 2021 | -19.11M |
| September 30, 2021 | -27.42M |
| June 30, 2021 | 1.890M |
| March 31, 2021 | -16.52M |
| December 31, 2020 | |
| September 30, 2020 | -6.050M |
| June 30, 2020 | -5.216M |
| March 31, 2020 | -3.889M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly & Co. | 10.69B |
| GH Research Plc | -14.94M |
| Johnson & Johnson | 8.616B |
| Merck & Co., Inc. | 5.37B |
| Zoetis, Inc. | 655.00M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 158.15M |
| Cash from Financing (Quarterly) | 2.625M |
| Free Cash Flow | -134.54M |
| Free Cash Flow Per Share (Quarterly) | -0.0973 |
| Free Cash Flow to Equity (Quarterly) | -34.98M |
| Free Cash Flow to Firm (Quarterly) | -35.09M |
| Free Cash Flow Yield | -5.85% |